Recurrent Esophageal Cancer Terminated Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0028797 (Recurrent Esophageal Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01249443Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTreatment